These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1161 related items for PubMed ID: 17256144

  • 1. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK, Kim S, Lee SS, Sym SJ, Lee DH, Jang S, Park CJ, Chi HS, Huh J, Suh C.
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [Abstract] [Full Text] [Related]

  • 2. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
    Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A, Sureda A, Zuazu J, Marin J, Arranz R, Carreras E, Leon A, De Sevilla AF, San Miguel JF, Conde E, GEL/TAMO Spanish Group.
    Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990
    [Abstract] [Full Text] [Related]

  • 3. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
    Papajik T, Raida L, Faber E, Vondrakova J, Prochazka V, Kubova Z, Skoumalova I, Jarosova M, M LK, Paucek B, Myslivecek M, Neoral C, Oral I, Jarkovsky J, Dusek L, Indrak K.
    Neoplasma; 2008 Dec; 55(3):215-21. PubMed ID: 18348654
    [Abstract] [Full Text] [Related]

  • 4. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
    Blystad AK, Enblad G, Kvaløy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H.
    Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
    [Abstract] [Full Text] [Related]

  • 5. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
    Rodríguez J, Conde E, Gutiérrez A, Arranz R, Gandarillas M, Leon A, Ojanguren J, Sureda A, Carrera D, Bendandi M, Moraleda J, Ribera JM, Albo C, Morales A, García JC, Fernández P, Cañigral G, Bergua J, Caballero MD, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea.
    Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
    [Abstract] [Full Text] [Related]

  • 6. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS, Kim K, Cheong JW, Min YH, Suh C, Kim H, Jo DY, Ryoo HM, Yoon SS, Lee JH, Korean Multiple Myeloma Working Party.
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [Abstract] [Full Text] [Related]

  • 7. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.
    Jantunen E, Wiklund T, Juvonen E, Putkonen M, Lehtinen T, Kuittinen O, Franssila K, Söderström KO, Leppä S, Elonen E, Remes K, Nousiainen T.
    Bone Marrow Transplant; 2004 Feb; 33(4):405-10. PubMed ID: 14676776
    [Abstract] [Full Text] [Related]

  • 8. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
    Mikesch JH, Kuhlmann M, Demant A, Krug U, Thoennissen GB, Schmidt E, Kessler T, Schliemann C, Pohlen M, Mohr M, Evers G, Köhler G, Wessling J, Mesters R, Müller-Tidow C, Berdel WE, Thoennissen NH.
    Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
    [Abstract] [Full Text] [Related]

  • 9. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Österborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Østenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE.
    J Clin Oncol; 2012 Sep 01; 30(25):3093-9. PubMed ID: 22851556
    [Abstract] [Full Text] [Related]

  • 10. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I.
    Bone Marrow Transplant; 2007 Oct 01; 40(7):651-8. PubMed ID: 17660837
    [Abstract] [Full Text] [Related]

  • 11. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
    Hirose A, Yamane T, Nakajima Y, Manabe M, Kanashima H, Hagihara K, Sakamoto E, Nakamae M, Terada Y, Kosaka S, Aoyama Y, Sakamoto C, Kumura T, Koh KR, Hirai M, Ohta K, Nakao Y, Mugitani A, Teshima H, Hino M.
    Gan To Kagaku Ryoho; 2005 Dec 01; 32(13):2059-64. PubMed ID: 16352929
    [Abstract] [Full Text] [Related]

  • 12. [Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases].
    Yu YX, Shi YK, He XH, Zhou LQ, Zhou SY, Dong M, Feng FY, Sun Y.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 16; 87(38):2714-6. PubMed ID: 18167252
    [Abstract] [Full Text] [Related]

  • 13. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
    Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ.
    Ann Hematol; 2013 Jun 16; 92(6):789-97. PubMed ID: 23358616
    [Abstract] [Full Text] [Related]

  • 14. Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group.
    Rodríguez J, Conde E, Gutiérrez A, Arranz R, León A, Marín J, Bendandi M, Albo C, Caballero MD, 'Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea' (GEL-TAMO).
    Eur J Haematol; 2007 Jul 16; 79(1):32-8. PubMed ID: 17598836
    [Abstract] [Full Text] [Related]

  • 15. Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Sohn BS, Park I, Kim EK, Yoon DH, Lee SS, Kang BW, Jang G, Choi YH, Kim C, Lee DH, Kim S, Huh J, Suh C.
    Bone Marrow Transplant; 2009 Sep 16; 44(5):287-93. PubMed ID: 19234508
    [Abstract] [Full Text] [Related]

  • 16. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases.
    Kim HJ, Bang SM, Lee J, Kwon HC, Suh C, Kim HJ, Lee JH, Ryoo BY, Park YH, Kwon JM, Oh SY, Lee HR, Kim K, Jung CW, Park K, Kim WS.
    Bone Marrow Transplant; 2006 May 16; 37(9):819-24. PubMed ID: 16547486
    [Abstract] [Full Text] [Related]

  • 17. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
    Ballova V, Ladicka M, Vranovsky A, Lakota J.
    Neoplasma; 2008 May 16; 55(5):428-36. PubMed ID: 18665754
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.
    Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M, Eto T, Fukuoka Blood and Marrow Transplantation Group.
    Bone Marrow Transplant; 2010 Feb 16; 45(2):311-6. PubMed ID: 19597416
    [Abstract] [Full Text] [Related]

  • 19. Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
    Smith SD, Bolwell BJ, Rybicki LA, Brown S, Dean R, Kalaycio M, Sobecks R, Andresen S, Hsi ED, Pohlman B, Sweetenham JW.
    Bone Marrow Transplant; 2007 Aug 16; 40(3):239-43. PubMed ID: 17530000
    [Abstract] [Full Text] [Related]

  • 20. Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.
    Kewalramani T, Zelenetz AD, Teruya-Feldstein J, Hamlin P, Yahalom J, Horwitz S, Nimer SD, Moskowitz CH.
    Br J Haematol; 2006 Jul 16; 134(2):202-7. PubMed ID: 16759221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.